Lmr Partners LLP Sorrento Therapeutics, Inc. Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 1,709,500 shares of SRNE stock, worth $564,135. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,709,500Holding current value
$564,135% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SRNE
# of Institutions
13Shares Held
5.51MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Kingswood Wealth Advisors, LLC San Diego, CA65.7KShares$21,6640.0% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.01% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...